Narayana Hrudayalaya shares jump over 9% following Q2 earnings; check key numbers, CEO's statement

The company, in its earnings press release, said that its consolidated total operating revenue was ₹1,643.8 crore in Q2 FY26 as compared to ₹1,366.7 crore seen in the corresponding period of the previous year, reflecting a change of +20.3% YoY and +9.1% QoQ.

It added that its consolidated EBITDA stood at ₹426.49 crore, reflecting a margin of 25.9% as against ₹332.3 crore in Q2 FY25, translating into a change of +28.3% YoY and +18.2% QoQ.

Further, it consolidated PAT stood at ₹258.3 crore, reflecting a margin of 15.7% as compared to ₹199.3 crore in Q2 FY25, translating into a change of +29.6% YoY and +31.7% QoQ.

The company further said its India operating revenue was ₹1,234.7 crore for Q2 FY26 as compared to ₹1,135.1 crore in the corresponding period of the previous year, reflecting a change of +8.8% YoY and +9.0% QoQ.

Cayman's operating revenue was ₹431.6 crore for Q2 FY26 as compared to ₹242.3 crore in the corresponding period of the previous year, reflecting a change of +78.1% YoY and +8.8% QoQ.

Management Comment

Commenting on the performance, Dr Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said, “The second quarter of the fiscal year has delivered a strong performance after a steady start to the year. We are pleased to report the highest-ever revenue and profitability at both India and the Group level."

The performance improvement in India is attributable to strong growth in domestic footfall and improvements in payor mix, along with positive traction from our clinic outreach, resulting in the highest-ever profitability margins.

"Our hospital business in Cayman continues to deliver robust performance, with the insurance business showing strong growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region. The domestic integrated care business continues to be on a strong growth path, with our clinics garnering sizeable footfalls across all locations, providing a positive thrust to the overall business," the CEO said.

Dr Rupert added, "After a steady start, our domestic insurance business has shown strong momentum this quarter, and we expect to build on this further going forward. We will continue to invest in this business and are optimistic that it will be a significant driver of growth to the NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year.”